Article
Heat shock phenocopies E1B-55K late functions and selectively sensitizes refractory tumor cells to ONYX-015 oncolytic viral therapy.
Cancer cell - 1 Jul 2005
O'Shea Clodagh C, Soria Conrado, Bagus Bridget, McCormick Frank
Abstract excerpt
ONYX-015 is an E1B-55K-deleted adenovirus that has promising clinical activity as a cancer therapy. However, many tumor cells fail to support ONYX-015 oncolytic replication. E1B-55K functions include p53 degradation, RNA export, and host protein shutoff. Here, we show that resistant tumor cell lines fail to provide the RNA export functions of E1B-55K necessary for ONYX-015 replication; viral 100K mRNA export is...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
